Evidence map›Paper›PMID 39617063›Full record

ArticleMolecular & cellular proteomics : MCP2025

Nuclear Factor I Family Members are Key Transcription Factors Regulating Gene Expression.

Dicle Malaymar Pinar, Helka Göös, Zenglai Tan, Esa-Pekka Kumpula, Iftekhar Chowdhury, Zixian Wang, Qin Zhang, Kari Salokas, Salla Keskitalo, Gong-Hong Wei and 2 more

Abstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. [Nuclear Factor I-X Regulates Molecular Pathways Related to Craniofacial Development Through Phase Separation].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2025
    Article
  10. Article
  11. Article
  12. Mechanistic insights intoFrontiers in genetics · 2025
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Dicle Malaymar PinarInstitute of Biotechnology, HiLIFE, University of Helsinki, Helsinki, Finland; Department of Molecular Biology and Genetics, Istanbul Technical University, Istanbul, Turkey.
Helka GöösiCell, Research and Development, Finnish Red Cross Blood Service, Helsinki, Finland.
Zenglai TanBiocenter Oulu and Faculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland.
Esa-Pekka KumpulaInstitute of Biotechnology, HiLIFE, University of Helsinki, Helsinki, Finland.
Iftekhar ChowdhuryInstitute of Biotechnology, HiLIFE, University of Helsinki, Helsinki, Finland.
Zixian WangMOE Key Laboratory of Metabolism and Molecular Medicine & Department of Biochemistry and Molecular Biology of School Basic Medical Sciences, Fudan University Shanghai Cancer Center, Shanghai Medical College of Fudan University, Shanghai, China.
Qin ZhangBiocenter Oulu and Faculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland.
Kari SalokasInstitute of Biotechnology, HiLIFE, University of Helsinki, Helsinki, Finland.
Salla KeskitaloInstitute of Biotechnology, HiLIFE, University of Helsinki, Helsinki, Finland.
Gong-Hong WeiBiocenter Oulu and Faculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland; MOE Key Laboratory of Metabolism and Molecular Medicine & Department of Biochemistry and Molecular Biology of School Basic Medical Sciences, Fudan University Shanghai Cancer Center, Shanghai Medical College of Fudan University, Shanghai, China.
Asli KumbasarDepartment of Molecular Biology and Genetics, Istanbul Technical University, Istanbul, Turkey.
Markku VarjosaloInstitute of Biotechnology, HiLIFE, University of Helsinki, Helsinki, Finland; iCAN Digital Precision Cancer Medicine Flagship, Faculty of Medicine, University of Helsinki, Helsinki, Finland. Electronic address: markku.varjosalo@helsinki.fi.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Nuclear Factor I (NFI) family of transcription factors (TFs) plays key roles in cellular differentiation, proliferation, and homeostasis. As such, NFI family members engage in a large number of interactions with other proteins and chromatin. However, despite their well-established significance, the NFIs' interactomes, their dynamics, and their functions have not been comprehensively examined. Here, we employed complementary omics-level techniques, i.e. interactomics (affinity purification mass spectrometry (AP-MS) and proximity-dependent biotinylation (BioID)), and chromatin immunoprecipitation sequencing (ChIP-Seq), to obtain a comprehensive view of the NFI proteins and their interactions in different cell lines. Our analyses included all four NFI family members, and a less-studied short isoform of NFIB (NFIB4), which lacks the DNA binding domain. We observed that, despite exhibiting redundancy, each family member had unique high-confidence interactors and target genes, suggesting distinct roles within the transcriptional regulatory networks. The study revealed that NFIs interact with other TFs to co-regulate a broad range of regulatory networks and cellular processes. Notably, time-dependent proximity-labeling unveiled a highly dynamic nature of NFI protein-protein interaction networks and hinted at the temporal modulation of NFI interactions. Furthermore, gene ontology (GO) enrichment analysis of NFI interactome and targetome revealed the involvement of NFIs in transcriptional regulation, chromatin organization, cellular signaling pathways, and pathways related to cancer. Additionally, we observed that NFIB4 engages with proteins associated with mRNA regulation, which suggests that NFIs have roles beyond traditional DNA binding and transcriptional modulation. We propose that NFIs may function as potential pioneering TFs, given their role in regulating the DNA binding ability of other TFs and their interactions with key chromatin remodeling complexes, thereby influencing a wide range of cellular processes. These insights into NFI protein-protein interactions and their dynamic, context-dependent nature provide a deeper understanding of gene regulation mechanisms and hint at the role of NFIs as master regulators.

Indexed as

Gene Expression RegulationNFI Transcription FactorsCell Line, TumorChromatin Immunoprecipitation SequencingGene Regulatory NetworksHumansProtein BindingTranscription FactorsNFI Transcription FactorsTranscription Factorsaffinity purificationBioIDChIP-seqinteraction proteomicsmass spectrometrynuclear factor Iprotein-protein interactionsproximity-dependent biotinylationtranscriptional regulationtranscription factors

Identifiers

PMID39617063
PMCPMC11775196

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.